Investing.com - Inari Med (NASDAQ: NARI) reported third quarter EPS of $0.05, $0.04 better than the analyst estimate of $0.01. Revenue for the quarter came in at $126.4M versus the consensus estimate of $121.92M.
Inari Med's stock price closed at $61.41. It is down -4.61% in the last 3 months and down -16.48% in the last 12 months.
Inari Med saw 7 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Inari Med's stock price’s past reactions to earnings here.
According to InvestingPro, Inari Med's Financial Health score is "good performance".
Check out Inari Med's recent earnings performance, and Inari Med's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar